CNO

CNO Financial Appoints New Chief Accounting Officer

CNO Financial Group, Inc. (NYSE: CNO) has recently appointed Joel Koehneman as its new Chief Accounting Officer, effective January 21, 2025. Koehneman brings with him 16 years of experience in the audit practice of PricewaterhouseCoopers (PwC), with a primary focus on life insurance clients. He has also served as a finance director at CDW Corporation over the past year.

Koehneman holds a bachelor's degree in accountancy and a master's degree in accounting science, both from the University of Illinois, and is a certified public accountant.

He takes over the position from Michellen Wildin, who is expected to remain with the company through April 1, 2025, to support the transition.

CNO Financial Group, Inc. secures the future of middle-income America by providing life and health insurance, annuities, financial services, and workforce benefits solutions. The company's family of brands includes Bankers Life, Colonial Penn, Optavise, and Washington National. CNO serves its customers with 3.2 million policies and $38 billion in total assets, guided by 3,500 associates, 4,800 exclusive agents, and more than 5,000 independent partner agents. Today the company's shares have moved 1.1% to a price of $37.55. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS